The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 10, 2024
Filed:
Oct. 27, 2023
Applicant:
Guangzhou Innocare Pharma Tech Co., Ltd., Guangzhou, CN;
Inventors:
Xiangyang Chen, Beijing, CN;
Yingxiang Gao, Beijing, CN;
Chong Liu, Beijing, CN;
Haihong Ni, Beijing, CN;
Assignee:
Guangzhou Innocare Pharma Tech Co., Ltd., Guangzhou, CN;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/04 (2006.01); A61K 31/444 (2006.01); A61P 35/00 (2006.01); C07D 211/34 (2006.01); C07D 213/82 (2006.01); C07D 231/14 (2006.01); C07D 277/56 (2006.01); C07D 295/185 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 417/04 (2006.01);
U.S. Cl.
CPC ...
C07D 417/04 (2013.01); A61K 31/444 (2013.01); A61P 35/00 (2018.01); C07D 211/34 (2013.01); C07D 213/82 (2013.01); C07D 231/14 (2013.01); C07D 277/56 (2013.01); C07D 295/185 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 413/04 (2013.01);
Abstract
Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).